0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bifidobacterium - Global Strategic Business Report

  • PDF Icon

    Report

  • 293 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6071204
The global market for Bifidobacterium was estimated at US$775.8 Million in 2024 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Bifidobacterium market.

Global Bifidobacterium Market - Key Trends & Drivers Summarized

Why Is Bifidobacterium Gaining Popularity in the Health and Wellness Industry?

Bifidobacterium, a genus of beneficial probiotics naturally found in the human gut, has become a focal point in the health and wellness industry due to its profound impact on digestive health, immunity, and overall well-being. As scientific research continues to highlight the crucial role of gut microbiota in maintaining health, consumer interest in probiotic supplements, functional foods, and personalized nutrition solutions has surged. Bifidobacterium is widely recognized for its ability to support gut health by balancing intestinal flora, improving digestion, and enhancing nutrient absorption. It also plays a pivotal role in strengthening the immune system, reducing inflammation, and mitigating gastrointestinal disorders such as irritable bowel syndrome (IBS) and lactose intolerance.

The rising prevalence of lifestyle-related health issues, including obesity, diabetes, and autoimmune conditions, has further driven demand for probiotics like Bifidobacterium. Functional foods and beverages enriched with probiotics, including yogurt, kefir, kombucha, and dietary supplements, have witnessed exponential growth as consumers seek natural ways to enhance their gut microbiome. Additionally, advancements in microbiome research have expanded the potential applications of Bifidobacterium beyond digestive health, with emerging studies linking its benefits to mental health, skin health, and metabolic regulation. As personalized nutrition gains traction, probiotic formulations tailored to individual microbiome compositions are set to revolutionize the market, positioning Bifidobacterium as a cornerstone of modern health solutions.

How Are Technological Advancements Enhancing Bifidobacterium-Based Products?

Technological innovations in probiotic formulation, delivery systems, and microbiome research have significantly improved the efficacy and stability of Bifidobacterium-based products. One of the most important advancements in this field is microencapsulation technology, which enhances the survivability of probiotics by protecting them from heat, moisture, and stomach acid. This ensures that a higher percentage of live bacteria reach the intestines, where they can exert their beneficial effects. Additionally, freeze-drying (lyophilization) techniques have improved the shelf life of Bifidobacterium probiotics, making them more viable for use in dietary supplements, functional foods, and pharmaceutical applications.

Another major breakthrough in probiotic science is the development of targeted strain-specific formulations that cater to specific health conditions. Researchers are identifying and isolating different strains of Bifidobacterium, such as Bifidobacterium longum, Bifidobacterium breve, and Bifidobacterium bifidum, each of which offers distinct health benefits. For example, certain strains have been shown to reduce symptoms of irritable bowel syndrome (IBS), while others improve cognitive function and reduce anxiety. The integration of DNA sequencing and artificial intelligence (AI) in microbiome analysis is further enhancing the precision of probiotic formulations, paving the way for personalized probiotic therapies. Moreover, advancements in symbiotic formulations - combining Bifidobacterium with prebiotics such as inulin or fructooligosaccharides (FOS) - are improving probiotic efficacy by fostering the growth and activity of beneficial bacteria in the gut.

Which Market Trends Are Driving the Growth of Bifidobacterium-Based Products?

The global Bifidobacterium market is expanding rapidly, fueled by the growing consumer shift toward natural health solutions and preventive healthcare. One of the most influential trends shaping the market is the increasing demand for functional foods and beverages infused with probiotics. Dairy-based probiotic products, including yogurt and fermented milk drinks, have long been dominant in the market, but plant-based and non-dairy alternatives are gaining traction due to the rise of vegan and lactose-intolerant consumers. Additionally, probiotic-fortified snacks, protein bars, and even coffee are emerging as innovative ways for consumers to incorporate beneficial bacteria into their daily diets.

Another key trend influencing the market is the rising awareness of the gut-brain axis, which highlights the connection between gut health and mental well-being. Studies have shown that certain strains of Bifidobacterium can influence neurotransmitter production, reduce stress, and improve mood. As a result, probiotics are being increasingly incorporated into mental wellness products, including cognitive-enhancing supplements and stress-relief formulations. Furthermore, the growing interest in pediatric probiotics has led to the development of infant formulas and children`s supplements containing Bifidobacterium to support immune system development and digestive health in early life. The expansion of online retail channels and direct-to-consumer sales is also playing a pivotal role in increasing accessibility and consumer education about the benefits of probiotics.

What Are the Key Growth Drivers Shaping the Future of the Bifidobacterium Market?

The growth in the Bifidobacterium market is driven by several critical factors, including increasing scientific validation of probiotics, rising consumer demand for gut health solutions, and advancements in biotechnology. One of the primary drivers is the expanding body of clinical research supporting the health benefits of Bifidobacterium, leading to greater acceptance among healthcare professionals and consumers. As more studies demonstrate its role in managing digestive disorders, boosting immunity, and even influencing mental health, the demand for high-quality probiotic products continues to rise. Additionally, regulatory approvals and health claims by organizations such as the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) are bolstering consumer confidence in probiotic efficacy and safety.

Another key driver shaping the market is the increasing investment in microbiome-focused startups and research initiatives. Biotech companies are developing next-generation probiotic formulations with enhanced bioavailability, stability, and targeted therapeutic applications. The expansion of probiotic applications into the pharmaceutical sector, including the development of Bifidobacterium-based drugs for gastrointestinal disorders and metabolic conditions, is expected to open new market opportunities. Additionally, the growing interest in sustainable and natural health solutions is driving innovation in probiotic production, with companies exploring fermentation-based and bioengineered methods to enhance probiotic strains. As consumer awareness of gut health continues to grow and scientific advancements unlock new probiotic functionalities, the Bifidobacterium market is poised for sustained expansion, shaping the future of personalized health and wellness solutions.

Scope of Study:

The report analyzes the Bifidobacterium market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Product Type (Bifidobacterium Longum, Bifidobacterium Breve, Bifidobacterium Animalis, Bifidobacterium Infantis, Bifidobacterium Lactis, Other Product Types); Application (Dietary Supplements Application, Animal Feed Application, Functional Food and Beverages Application, Pharmaceuticals Application, Other Applications)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Bifidobacterium Longum segment, which is expected to reach US$244.9 Million by 2030 with a CAGR of a 8.3%. The Bifidobacterium Breve segment is also set to grow at 7.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $211.4 Million in 2024, and China, forecasted to grow at an impressive 10.7% CAGR to reach $240.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Bifidobacterium Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Bifidobacterium Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Bifidobacterium Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as BioGaia, BioGrowing Co., Ltd, Chr. Hansen Holding A/S, Danone S.A, DSM-Firmenich AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Bifidobacterium market report include:

  • BioGaia
  • BioGrowing Co., Ltd
  • Chr. Hansen Holding A/S
  • Danone S.A
  • DSM-Firmenich AG
  • DuPont de Nemours, Inc.
  • Garden of Life
  • General Mills, Inc.
  • Kerry Group Plc
  • Lallemand, Inc.
  • Morinaga Milk Industry Co., Ltd.
  • Nestle S.A.
  • Probi AB
  • Valio Oy
  • Yakult Honsha Co., Ltd.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Bifidobacterium - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Focus on Gut Health and Microbiome Wellness Throws the Spotlight on Bifidobacterium-Based Products
  • Rising Demand for Probiotic-Rich Functional Foods Drives Market Growth for Bifidobacterium Strains
  • Increasing Consumer Awareness of Digestive and Immune Health Expands Addressable Market Opportunity
  • Scientific Validation of Bifidobacterium`s Role in Microbiota Balance Strengthens the Business Case for Probiotic Supplementation
  • Surge in Prebiotic and Synbiotic Product Development Spurs Innovation in Bifidobacterium Combinations
  • Growth of Personalized Nutrition and Microbiome Testing Accelerates Demand for Targeted Bifidobacterium Strains
  • Rising Incidence of Antibiotic-Associated Gut Dysbiosis Propels Use of Bifidobacterium in Post-Antibiotic Therapy
  • Infant and Pediatric Nutrition Segment Drives High Demand for Bifidobacterium-Infused Formulas and Supplements
  • Clean Label and Natural Health Product Trends Fuel Interest in Fermented Foods Containing Bifidobacterium Cultures
  • Expanding Use of Bifidobacterium in Women`s Health and Metabolic Wellness Products Creates New Market Opportunities
  • Growth in Aging Population and Cognitive Wellness Awareness Spurs Bifidobacterium Application in Healthy Aging Products
  • Advancements in Encapsulation and Delivery Technologies Enhance Viability and Shelf-Stability of Bifidobacterium Products
  • Rising Interest in Mental Wellness and Gut-Brain Axis Fuels Demand for Psychobiotic Bifidobacterium Strains
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bifidobacterium Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bifidobacterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bifidobacterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Bifidobacterium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bifidobacterium Longum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bifidobacterium Longum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Bifidobacterium Longum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Bifidobacterium Breve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Bifidobacterium Breve by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Bifidobacterium Breve by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Bifidobacterium Animalis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Bifidobacterium Animalis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Bifidobacterium Animalis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Bifidobacterium Infantis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Bifidobacterium Infantis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Bifidobacterium Infantis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Bifidobacterium Lactis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Bifidobacterium Lactis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Bifidobacterium Lactis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Animal Feed Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Animal Feed Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Animal Feed Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Functional Food & Beverages Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Functional Food & Beverages Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Functional Food & Beverages Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • CANADA
  • JAPAN
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • CHINA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • EUROPE
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • FRANCE
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • GERMANY
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • ITALY
  • UNITED KINGDOM
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • AUSTRALIA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • INDIA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
  • Bifidobacterium Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioGaia
  • BioGrowing Co., Ltd
  • Chr. Hansen Holding A/S
  • Danone S.A
  • DSM-Firmenich AG
  • DuPont de Nemours, Inc.
  • Garden of Life
  • General Mills, Inc.
  • Kerry Group Plc
  • Lallemand, Inc.
  • Morinaga Milk Industry Co., Ltd.
  • Nestle S.A.
  • Probi AB
  • Valio Oy
  • Yakult Honsha Co., Ltd.
This website uses cookies to ensure you get the best experience. Learn more